Evidence map›Paper›PMID 37207117›Full record

ArticleAcute medicine & surgery

Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub-analysis of the DIANA study Japanese data.

Chie Tanaka, Takashi Tagami, Masamune Kuno, Kyoko Unemoto, DIANA Study Japanese Group

Abstract read
In one paragraph

Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chie TanakaDepartment of Emergency and Critical Care Medicine Nippon Medical School Tama Nagayama Hospital Tama-shi Tokyo Japan.
Takashi TagamiDepartment of Emergency and Critical Care Medicine Nippon Medical School Musashikosugi Hospital Kawasaki Kanagawa Japan.ORCID https://orcid.org/0000-0001-6953-1932
Masamune KunoDepartment of Emergency and Critical Care Medicine Nippon Medical School Tama Nagayama Hospital Tama-shi Tokyo Japan.
Kyoko UnemotoDepartment of Emergency and Critical Care Medicine Nippon Medical School Tama Nagayama Hospital Tama-shi Tokyo Japan.ORCID https://orcid.org/0000-0002-8551-2712
DIANA Study Japanese Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is not clear whether evaluating the clinical response to antibiotic use at day 7 among critically ill patients accurately predicts outcomes. We aimed to evaluate the relationship between clinical response to the initial empiric therapy on day 7 and mortality. Methods: The determinants of antimicrobial use and de-escalation in critical care (DIANA) study was an international, multicenter, observational study on antibiotic use in the intensive care unit (ICU). ICU patients ages over 18 years in whom an empiric antimicrobial regimen in Japan was initiated were included. We compared patients who were evaluated as cured or improved ("effective") 7 days after starting antibiotic treatment with patients who were evaluated as deteriorated ("failure"). Results: Overall, 217 (83%) patients were in the effective group, and 45 (17%) were in the failure group. Both the infection-related mortality rate in the ICU and the in-hospital infection-related mortality rate in the effective group were lower than those in the failure group (0% versus 24.4%; Conclusion: Assessment of efficacy of empiric antimicrobial treatment on day 7 may predict a favorable outcome among patients suffering from infection in the ICU.

Indexed as

Antibioticsclinical responseinfectionintensive care unitmortality

Identifiers

PMID37207117
PMCPMC10189631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.